PhysioAge
PhysioAge is a New York-based health-analytics SaaS company offering a biomarker-tracking and longevity-medicine platform to physicians, clinics, and individual subscribers on monthly subscriptions starting at $300.
- Company typePrivate
- Founded2008
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What PhysioAge does
PhysioAge, operating as PhysioAge Systems LLC, is a New York-based health-analytics SaaS company that builds software for biomarker-driven longevity medicine. The platform collects, analyzes, and visualizes patient lab and diagnostic data to produce custom scorecards and reports for physicians and patients. Its technical core is the integration of validated biomarkers of aging — CardioAge, PhenoAge, TruAge, and GlycanAge — with a proprietary PhysioAge Aggregate Age calculation spanning up to 7 biological systems, covering 800+ biomarkers in total. Letter-grade (A through F) scoring and optimal-range referencing (derived from scientific literature rather than conventional normal ranges) are positioned as the clinical differentiators. The product surface consists of the web-based PhysioAge Health Analytics tool, the PhysioAge App on iOS and Android, and a suite of Patient, Physician, and Visit-Summary PDF reports, with an optional Practice Analytics add-on providing practice-wide population views.
PhysioAge is physician-owned, with no disclosed external venture or institutional capital. It was originally developed and validated inside Dr. Joseph Raffaele's clinical practice (Raffaele Medical) before being commercialized to other clinics; the company has been active in longevity medicine since the founder's research program began in 1995 and was spun into a software business in 2008. Revenue is generated primarily through recurring monthly subscriptions starting at $300 per individual user, with no commitment or implementation fee, and secondarily through fee-for-service clinical assessment packages that provider practices build into their service mix. Distribution is split between enterprise direct sales to physicians and clinics and self-serve consumer acquisition through the website, iOS App Store, and Google Play Store.
The firm operates in a narrow and growing niche — longevity and preventive medicine — targeting physicians seeking practice differentiation through biomarker tracking and health-conscious individuals seeking biological-age monitoring. Customer concentration evidence is limited: only Raffaele Medical is named as a customer, the company is founder-led by Dr. Raffaele (Co-Founder and CEO) with co-founder Jerry Fortunato and CTO J. Daniel Powell, and its go-to-market relies heavily on founder-driven thought leadership through the Longevity Insights blog, organic social channels, and recurring PR placements in outlets such as the New York Times, Wired, NPR, and NBC. No certifications, patents, partnerships, integrations, APIs, or regulatory milestones are disclosed in the source data.
PhysioAge firmographics
Firmographics- Name
- PhysioAge
- Legal name
- PhysioAge Systems LLC
- Website
- https://physioage.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PhysioAge is a New York-based health-analytics SaaS company offering a biomarker-tracking and longevity-medicine platform to physicians, clinics, and individual subscribers on monthly subscriptions starting at $300.
- Ownership category
- akta.pro rank
PhysioAge industry classification
Industry- Product category
- Health Analytics Software
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)
- akta.pro secondary industries
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
Keywords
Where PhysioAge is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
PhysioAge business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Subscription Analytics Platform: Healthcare providers and patients pay recurring subscription fees to access the PhysioAge health analytics platform, including web-based software, the PhysioAge App, patient reports, and physician reports. Pricing starts at $300/month for individual users.
- Assessment Services: Fee-for-service model where practices offer biomarker assessments as a differentiated service offering, generating revenue from individual patient assessments that can be built into regular service packages.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Individual Patient Subscription starting at $300/month |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
PhysioAge product offering
Product offeringCore offering
PhysioAge provides a web-based health analytics software platform that collects patient biomarker data, generates custom physiological aging scorecards, and delivers both patient-facing and physician-facing reports to support longevity and preventive medicine decision-making. The platform is offered as a subscription to individual patients and licensed to physicians and concierge practices for use in clinical consultations.
Product overview
PhysioAge is a longevity medicine platform consisting of a core Health Analytics web-based software platform and mobile PhysioAge App. The platform integrates Patient Reports, Physician's Reports, and Visit Summaries to enable healthcare providers to track validated biomarkers of aging (CardioAge, PhenoAge, TruAge, GlycanAge), generate letter-graded scorecards, and deliver personalized health recommendations. An optional Practice Analytics module provides practice-wide population health insights. Pricing starts at $300/month with no commitment or investment required.
Differentiator
Problem solved
Functional benefit
Products and services
- PhysioAge Health Analytics Platform
- PhysioAge Mobile App
- Practice Analytics
Quantifiable outcome
- 800+ biomarkers tracked and explained for comprehensive biological age assessment
- +2 more outcomes
Companies that use PhysioAge
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
PhysioAge technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
PhysioAge partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights4 records
PhysioAge competitors and assessment
Company assessmentDirect peers
- InsideTracker: InsideTracker is a direct competitor offering blood biomarker analytics with personalized recommendations for individuals and corporate wellness programs, addressing the same preventive longevity use cases as PhysioAge through a similar SaaS-plus-D2C model.
- Function Health: Function Health offers comprehensive lab testing with structured longitudinal health insights for consumers, directly competing with PhysioAge's biomarker-driven preventive health analytics and membership model.
- TruDiagnostic: TruDiagnostic provides epigenetic biological age testing (one of the same biomarkers - TruAge - used by PhysioAge) with provider and consumer offerings, making it a tight technical peer in the validated aging biomarker category.
- Elysium Index: Elysium's Index product delivers biological age testing and longitudinal biomarker tracking for consumers, overlapping with PhysioAge's aggregate-age and biomarker scorecard value proposition.
- TallyHealth: TallyHealth sells a biological age test plus personalized longevity program for consumers, competing in the same preventative longevity analytics space that PhysioAge targets through its provider-led model.
Broad incumbents
- Thorne: Thorne is a much larger supplements-and-health-data company with its own at-home biomarker tests (Thorne Healthspan) that sits adjacent to PhysioAge's biomarker analytics offering, drawing on similar consumer longevity demand.
- Human Longevity Inc: Human Longevity Inc. is a broader enterprise longevity-diagnostics player combining genomics, imaging, and biomarker analytics for premium executive health programs, serving as a broader incumbent in the same longevity diagnostics category.
- Fountain Life: Fountain Life operates a network of longevity-focused clinics offering advanced diagnostics and biomarker-driven health optimization, making it comparable as a broader incumbent in the provider-side longevity medicine market.
Emerging players
- Lifeforce: Lifeforce is a digital healthspan membership combining at-home biomarker testing, supplements, and clinician consultations - an emerging consumer longevity platform that overlaps with PhysioAge's biomarker-tracking core.
- Biopeak: Biopeak is a newer healthspan platform offering advanced biomarker testing and personalized longevity programs for individuals, making it a relevant emerging peer in preventive longevity analytics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
PhysioAge social profiles
Digital presencePhysioAge financial estimates
Financial estimateRevenue estimate
Valuation estimate
PhysioAge leadership team
Management profileNumber of profiles
Profiles5 records
PhysioAge funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PhysioAge M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PhysioAge
What does PhysioAge do?
PhysioAge provides a web-based health analytics software platform that collects patient biomarker data, generates custom physiological aging scorecards, and delivers both patient-facing and physician-facing reports to support longevity and preventive medicine decision-making. The platform is offered as a subscription to individual patients and licensed to physicians and concierge practices for use in clinical consultations.
Is PhysioAge a public or private company?
PhysioAge is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was PhysioAge founded?
PhysioAge was founded in 2008. It employs 11 to 50 people.
Where is PhysioAge based?
PhysioAge is headquartered in New York, United States, in the North America region.
How does PhysioAge make money?
Two revenue lines are on record. Subscription Analytics Platform is the primary driver. The others are assessment Services.
Who are PhysioAge's main competitors?
Direct peers on record are InsideTracker, Function Health, TruDiagnostic, Elysium Index and TallyHealth. Broad incumbents are Thorne, Human Longevity Inc and Fountain Life. Emerging players are Lifeforce and Biopeak.
Does PhysioAge have an API?
No public API is recorded for PhysioAge.
What industry is PhysioAge in?
PhysioAge's product category is Health Analytics Software. Its primary akta.pro industry code is HLACAPAK, Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its SIC code is 7372.